A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide ISA-51 VG With Bevacizumab for Patients With Recurrent Glioblastoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
A Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Cisplatin-Pemetrexed Compared With Carboplatin-Paclitaxel-Bevacizumab in KRAS Mutated Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Optune® Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE2
A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study of Atezolizumab + Bevacizumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
PRP vs Bevacizumab for PDR Treatment
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Bevacizumab and Nimustine in Patients With Recurrent High Grade Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Radiation Therapy in Treating Patients With Recurrent Brain Tumors Who Have Undergone Previous Radiation Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Fractionated Stereotactic Radiosurgery With Concurrent Bevacizumab for Brain Metastases: A Phase I Dose-escalation Trial
- Status
- UNKNOWN
- Phase
- PHASE1
A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Capecitabine + Bevacizumab in Patients With Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Study Evaluating the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD), and Therapeutic Activity of Selicrelumab (RO7009789) With Vanucizumab or Bevacizumab in Participants With Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN)
- Status
- TERMINATED
- Phase
- PHASE2
TTFields and Pulsed Bevacizumab for Recurrent Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE2
A Phase 1b Study of Paclitaxel And Ricolinostat For The Treatment Of Gynecological Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Anti-programmed Cell Death-1 Ligand 1 (aPDL-1) Antibody Atezolizumab, Bevacizumab and Acetylsalicylic Acid in Recurrent Platinum Resistant Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Ph 2 Study of TAS-102 / Bevacizumab Maintenance Therapy Post Induction Chemotherapy in Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Alternative Dosing for CRLX101(NLG207) Alone, With Avastin and With mFOLFOX6 in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1